|
Market Closed -
London S.E.
07:30:00 01/05/2025 BST
|
5-day change | 1st Jan Change | ||
| 0.2250 GBX | -.--% |
|
+2.27% | - |
| 03-01 | Kanabo Group PLC Announces Termination Of Director Appointment of Sharon Malka, Effective February 27, 2026 | CI |
| 12-12 | Quantum Helium increases Sagebrush project interest | AN |
| Market Cap | 5.38M 7.11M 6.44M 5.96M 10.13M 670M 10.49M 71.57M 28.38M 358M 26.68M 26.11M 1.14B | P/E 2022 |
-1.15x | P/E 2023 | -1.88x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 3.22M 2.92M 2.7M 4.59M 304M 4.76M 32.46M 12.87M 162M 12.1M 11.84M 515M | EV / Sales 2022 |
8.33x | EV / Sales 2023 | 16.5x |
| Free-Float |
96.57% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +2.27% | ||
| Current month | +2.27% | ||
| 1 month | +2.27% | ||
| 3 months | +2.27% |
| Current year | 0.22 |  | 0.22 |
| 1 year | 0.22 | | 0.22 |
| 3 years | 0.15 | | 3.2 |
| 5 years | 0.15 | | 16.5 |
| 10 years | 0.15 | | 51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | 45 | 27/06/2021 |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
BRD | Director/Board Member | 45 | 27/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/10/24 | Others | Chairman | 18,011,111 | 2.8479% | ||
| 29/10/24 | Free | Chairman | 17,361,111 | 2.7452% | ||
| 28/08/24 | Buy | Chief Technology Officer | 75,187 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +2.27% | -.--% | -82.35% | 1.84M | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | +0.24% | +0.87% | +31.85% | +66.79% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.50% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 603K 797K 723K 668K 1.14M 75.18M 1.18M 8.03M 3.18M 40.16M 2.99M 2.93M 127M | 895K 1.18M 1.07M 992K 1.69M 112M 1.75M 11.92M 4.73M 59.61M 4.44M 4.35M 189M |
| Net income | -6.87M -9.08M -8.23M -7.61M -12.94M -856M -13.4M -91.43M -36.25M -457M -34.08M -33.35M -1.45B | -7.99M -10.56M -9.57M -8.85M -15.05M -996M -15.58M -106M -42.17M -532M -39.63M -38.79M -1.69B |
| Net Debt | -3.01M -3.98M -3.61M -3.34M -5.68M -376M -5.88M -40.1M -15.9M -201M -14.95M -14.63M -637M | -2.94M -3.88M -3.52M -3.26M -5.54M -366M -5.73M -39.12M -15.51M -196M -14.58M -14.27M -621M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- KNB Stock
Select your edition
All financial news and data tailored to specific country editions
